Can-Fite to explore the anti-coronavirus effects of piclidenoson in collaboration with Lewis Katz School of Medicine at Temple University

This article was originally published here

The agreement will support research directed by Dr. Kamel Khalili, aimed to explore anti-viral activity of Piclidenoson on Coronaviruses viral load in a mammalian cell model system as

The post Can-Fite to explore the anti-coronavirus effects of piclidenoson in collaboration with Lewis Katz School of Medicine at Temple University appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply